|
Market Closed -
Euronext Paris
18:55:00 02/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 19.80 EUR | -0.25% |
|
+1.02% | -34.65% |
| 09-17 | Boiron SA Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 04-22 | Boiron SA Reports Earnings Results for the Full Year Ended December 31, 2025 | CI |
| Market Cap | 345M 388M 322M 293M 553M 37.29B 558M 3.89B 1.51B 19.06B 1.46B 1.42B 61.18B | P/E 2024 |
41x | P/E 2025 | 16.1x |
|---|---|---|---|---|---|
| Enterprise Value | 297M 334M 277M 252M 476M 32.11B 481M 3.35B 1.3B 16.42B 1.25B 1.23B 52.68B | EV / Sales 2024 |
0.85x | EV / Sales 2025 | 0.95x |
| Free-Float |
19.96% | Yield 2024 |
4.48% | Yield 2025 | 4.46% |
Euronext ParisEUR
| Markets | Quality | ||
|---|---|---|---|
Euronext Paris
| BOI | Real-time | |
OTC Markets
| BOIRF | Delayed | |
Börse Stuttgart
| BON | Delayed | |
CBOE
| BOIp | Real-time | |
Deutsche Boerse AG
| BON | Delayed | |
CBOE
| 0DTF | Real-time | |
Boerse Muenchen
| BON | Real-time |
| 1 day | -0.25% | ||
| 1 week | +1.02% | ||
| Current month | -1.00% | ||
| 1 month | -24.43% | ||
| 3 months | -28.26% | ||
| 6 months | -29.29% | ||
| Current year | -34.65% |
| 1 week | 19.3 | 20.9 | |
| 1 month | 19.3 | 26.7 | |
| Current year | 19.3 | 30.95 | |
| 1 year | 19.3 | 32.25 | |
| 3 years | 19.3 | 56.5 | |
| 5 years | 19.3 | 56.5 | |
| 10 years | 19.3 | 92.91 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Houdayer
CEO | Chief Executive Officer | 57 | 01/01/2025 |
Frédéric Riou
CTO | Chief Tech/Sci/R&D Officer | - | - |
Isabelle Chanel
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Thierry Boiron
CHM | Chairman | 65 | 01/07/2011 |
| Director/Board Member | 54 | 10/03/2010 | |
| Director/Board Member | 51 | 23/05/2013 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/29/23 A | Sell | Director | 198,664 | 1.1323% | ||
| 10/29/23 A | Sell | Director | 462,964 | 2.6387% | ||
| 10/29/23 A | Sell | Director | 4,748 | 0.0271% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -0.25% | +1.02% | -26.39% | -63.33% | 388M | ||
| -0.31% | -3.28% | +39.62% | +112.65% | 1,025B | ||
| -1.23% | -5.87% | +37.27% | +64.55% | 623B | ||
| +1.42% | -0.44% | +11.25% | +77.52% | 459B | ||
| +0.23% | -3.22% | +60.86% | +40.41% | 355B | ||
| -0.95% | -4.05% | +21.60% | +39.37% | 336B | ||
| -1.46% | -2.89% | +11.84% | +24.60% | 270B | ||
| -1.35% | -5.43% | -4.69% | +8.40% | 247B | ||
| -0.95% | -2.75% | +35.57% | +51.40% | 220B | ||
| -2.08% | -4.18% | +30.81% | +95.17% | 183B | ||
| Average | -0.72% | -2.20% | +21.78% | +45.07% | 371.86B | |
| Weighted average by Cap. | -0.56% | -2.42% | +30.49% | +68.92% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 488M 549M 455M 415M 782M 52.75B 790M 5.51B 2.13B 26.97B 2.06B 2.02B 86.55B | 501M 564M 468M 426M 804M 54.22B 811M 5.66B 2.19B 27.72B 2.12B 2.07B 88.95B |
| Net income | 11.34M 12.76M 10.58M 9.64M 18.19M 1.23B 18.36M 128M 49.62M 627M 47.9M 46.86M 2.01B | 32.64M 36.74M 30.47M 27.77M 52.37M 3.53B 52.86M 369M 143M 1.81B 138M 135M 5.79B |
| Net Debt | -49.74M -55.98M -46.42M -42.31M -79.8M -5.38B -80.54M -562M -218M -2.75B -210M -206M -8.83B | -47.86M -53.86M -44.66M -40.71M -76.78M -5.18B -77.49M -541M -209M -2.65B -202M -198M -8.49B |
Employees
2,623
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/10/26 | €19.80 | -0.25% | 5,364 |
| 01/10/26 | €19.85 | -0.75% | 5,359 |
| 30/09/26 | €20.00 | 0.00% | 2,870 |
| 29/09/26 | €20.00 | +0.25% | 2,684 |
| 28/09/26 | €19.95 | +1.79% | 1,957 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- BOI Stock
Select your edition
All financial news and data tailored to specific country editions

















